Latest Insider Transactions at Celsion Corp (CLSN)
This section provides a real-time view of insider transactions for Celsion Corp (CLSN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Celsion CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Celsion CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 07
2023
|
Sebastien Hazard Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Jul 18
2022
|
Corinne Le Goff President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
53,000
+50.0%
|
-
|
|
Apr 12
2022
|
Michael H Tardugno Executive Chairman of Board |
BUY
Open market or private purchase
|
Direct |
4,000
+19.5%
|
$12,000
$3.53 P/Share
|
|
Apr 08
2022
|
Frederick J. Fritz Director |
BUY
Open market or private purchase
|
Direct |
5,000
+29.82%
|
$20,000
$4.05 P/Share
|
|
Mar 02
2022
|
Frederick J. Fritz Director |
BUY
Open market or private purchase
|
Direct |
2,000
+22.82%
|
$8,000
$4.69 P/Share
|
|
Dec 14
2021
|
Constantine John Kardaras Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Oct 07
2021
|
Frederick J. Fritz Director |
BUY
Open market or private purchase
|
Direct |
20,000
+21.86%
|
$0
$0.88 P/Share
|
|
May 17
2021
|
Donald P Braun Director |
BUY
Open market or private purchase
|
Direct |
5,000
+48.28%
|
$5,000
$1.07 P/Share
|